Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 017378

Expand all

PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER (MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE)
30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Marketing Status: Prescription

Active Ingredient: MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
Proprietary Name: PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017378
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

PLASMA-LYTE A IN PLASTIC CONTAINER (MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE)
30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Marketing Status: Prescription

Active Ingredient: MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
Proprietary Name: PLASMA-LYTE A IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 30MG/100ML;37MG/100ML;368MG/100ML;526MG/100ML;502MG/100ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N017378
Product Number: 002
Approval Date: Nov 22, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information